|
pubmed:abstractText |
Prior 8-week treatment with menatetrenone, MK-4, followed by 8-week risedronate prevented the shortcomings of individual drugs and significantly increased the strength of ovariectomized ICR mouse femur compared to the ovariectomized (OVX) controls. Neither MK-4 following risedronate nor the concomitant administration may be recommended because they brought the least beneficial effect.
|
|
pubmed:affiliation |
Division of Radiology, Department of Maxillofacial Diagnostic Science, Kanagawa Dental College, 82 Inaokacho, Yokosuka, Kanagawa, 238-8580, Japan.
|
